# Nuclide record caix (target). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/targets/caix/>
  a schema:BioChemEntity ;
  nuclide:kind "target" ;
  schema:identifier "caix" ;
  schema:name "CAIX (carbonic anhydrase IX)"@en ;
  schema:alternateName "CA9"@en, "G250 antigen"@en, "MN antigen"@en, "CA9" ;
  schema:description "A protein that clear cell kidney cancer makes almost all the time because of a gene fault. It helps the tumour survive in low-oxygen conditions, and antibodies that stick to it can be used to find or treat the cancer."@en ;
  schema:url <https://nuclide.cc/targets/caix/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://pmc.ncbi.nlm.nih.gov/articles/PMC7582814/>, <https://pmc.ncbi.nlm.nih.gov/articles/PMC12976585/>, <https://www.spandidos-publications.com/10.3892/ijo.2014.2658/download>, <https://jnm.snmjournals.org/content/65/5/744> ;
  nuclide:tag "renal cell carcinoma", "hypoxia", "antibody target" ;
  nuclide:targetClass "enzyme" ;
  nuclide:related <https://nuclide.cc/drugs/girentuximab-zr89/>, <https://nuclide.cc/technologies/caix-pet/>, <https://nuclide.cc/indications/rcc/>, <https://nuclide.cc/pathways/hif-vhl/>, <https://nuclide.cc/ideas/idea-caix-theranostics/>, <https://nuclide.cc/trials/nct06750419/>, <https://nuclide.cc/trials/nct07197580/>, <https://nuclide.cc/companies/telix/>, <https://nuclide.cc/isotopes/ga-68/> .
